Position in ACRV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,768,324
+$10,175,018 QoQ
Shares Held
12,229,396
+46.6% QoQ
Ownership
28.5%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1
of 46 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. ACRV ranks #57 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
10,281,496 | $2,742,280,613 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
28,933,371 | $791,906,364 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
6,666,837 | $740,218,912 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
11,474,599 | $667,018,439 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $435,722,929 | |
| 6 | TYRA |
Tyra Biosciences, Inc.
|
12,198,625 | $389,624,082 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
8,392,730 | $340,996,619 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,883,524 | $330,779,298 |
All Filings in ACRV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,768,324 | 12,229,396 | Shares | Sole | 2026-08-14 | |
| 2026-04-22 | $24,201,264 | 12,284,906 | Shares | Sole | 2026-04-23 | |
| 2026-03-31 | $11,593,306 | 8,340,508 | Shares | Sole | 2026-05-15 | |
| 2026-03-19 | $14,273,230 | 8,396,018 | Shares | Sole | 2026-03-23 | |
| 2025-12-31 | $20,100,624 | 8,340,508 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,096,319 | 8,340,508 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,925,204 | 8,340,508 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,931,231 | 8,340,508 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $50,209,858 | 8,340,508 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $58,383,556 | 8,340,508 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $48,374,946 | 8,340,508 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $34,395,132 | 4,810,508 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $23,667,699 | 4,810,508 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $45,988,456 | 4,810,508 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $62,344,183 | 4,810,508 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $61,045,346 | 4,810,508 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $55,417,052 | 4,810,508 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||